The Association Between CD40 rs1883832 Polymorphism and Cancer Susceptibility: A Systematic Review and Meta‐Analysis
A comprehensive meta‐analysis provides compelling evidence that the CD40 rs1883832 T allele may confer increased susceptibility to cancer, thereby underscoring the potential influence of immune gene polymorphisms in carcinogenesis and their relevance for genetic risk assessment in oncology.